2021 Q4 Form 10-K Financial Statement
#000149315222008452 Filed on March 31, 2022
Income Statement
| Concept | 2021 Q4 | 2021 | 2020 Q4 |
|---|---|---|---|
| Revenue | $4.394M | $16.89M | $3.310M |
| YoY Change | 32.76% | 29.19% | 8.17% |
| Cost Of Revenue | $1.287M | $4.281M | $620.0K |
| YoY Change | 107.61% | 61.55% | -28.74% |
| Gross Profit | $3.107M | $12.60M | $2.690M |
| YoY Change | 15.51% | 21.08% | 22.83% |
| Gross Profit Margin | 70.71% | 74.65% | 81.27% |
| Selling, General & Admin | $9.439M | $31.34M | $5.430M |
| YoY Change | 73.83% | 70.34% | 19.6% |
| % of Gross Profit | 303.78% | 248.67% | 201.86% |
| Research & Development | $200.0K | ||
| YoY Change | |||
| % of Gross Profit | 1.59% | ||
| Depreciation & Amortization | $168.2K | $733.0K | $180.0K |
| YoY Change | -6.54% | 1.81% | 0.0% |
| % of Gross Profit | 5.41% | 5.82% | 6.69% |
| Operating Expenses | $9.607M | $32.08M | $8.930M |
| YoY Change | 7.59% | 42.81% | 89.6% |
| Operating Profit | -$6.500M | -$19.47M | -$6.240M |
| YoY Change | 4.17% | 61.59% | 147.62% |
| Interest Expense | $27.28K | $103.0K | $0.00 |
| YoY Change | -615.0% | -100.0% | |
| % of Operating Profit | |||
| Other Income/Expense, Net | -$9.000K | -$9.000K | |
| YoY Change | |||
| Pretax Income | -$7.393M | -$20.29M | -$6.250M |
| YoY Change | 18.29% | 68.23% | 137.64% |
| Income Tax | $0.00 | ||
| % Of Pretax Income | |||
| Net Earnings | -$7.393M | -$20.29M | -$6.250M |
| YoY Change | 18.29% | 68.23% | 137.64% |
| Net Earnings / Revenue | -168.24% | -120.15% | -188.82% |
| Basic Earnings Per Share | -$0.96 | ||
| Diluted Earnings Per Share | -$321.0K | -$955.5K | -$314.9K |
| COMMON SHARES | |||
| Basic Shares Outstanding | 21.23B shares | ||
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2021 Q4 | 2021 | 2020 Q4 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $24.03M | $24.03M | $18.21M |
| YoY Change | 31.96% | 31.96% | |
| Cash & Equivalents | $24.03M | $24.03M | $18.21M |
| Short-Term Investments | |||
| Other Short-Term Assets | $2.091M | $2.091M | $670.0K |
| YoY Change | 212.09% | 212.09% | |
| Inventory | |||
| Prepaid Expenses | |||
| Receivables | $1.203M | $1.203M | $1.520M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $27.32M | $27.32M | $20.39M |
| YoY Change | 34.01% | 34.01% | |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $2.825M | $2.825M | $870.0K |
| YoY Change | 224.71% | 224.71% | |
| Goodwill | $2.843M | ||
| YoY Change | |||
| Intangibles | $341.0K | ||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $356.0K | $356.0K | $310.0K |
| YoY Change | 14.84% | 14.84% | |
| Total Long-Term Assets | $6.365M | $6.365M | $4.940M |
| YoY Change | 28.85% | 28.85% | |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $27.32M | $27.32M | $20.39M |
| Total Long-Term Assets | $6.365M | $6.365M | $4.940M |
| Total Assets | $33.69M | $33.69M | $25.33M |
| YoY Change | 33.0% | 33.0% | |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $920.0K | $920.0K | $2.280M |
| YoY Change | -59.65% | -59.65% | |
| Accrued Expenses | $2.853M | $2.853M | $1.740M |
| YoY Change | 63.97% | 63.97% | |
| Deferred Revenue | $2.399M | ||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $1.334M | $1.334M | $870.0K |
| YoY Change | 53.33% | 53.33% | |
| Total Short-Term Liabilities | $7.509M | $7.509M | $7.820M |
| YoY Change | -3.98% | -3.98% | |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $298.0K | $420.0K | |
| YoY Change | -29.05% | ||
| Other Long-Term Liabilities | $343.0K | $343.0K | $160.0K |
| YoY Change | 114.38% | 114.38% | |
| Total Long-Term Liabilities | $0.00 | $641.0K | $580.0K |
| YoY Change | -100.0% | 10.52% | |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $7.509M | $7.509M | $7.820M |
| Total Long-Term Liabilities | $0.00 | $641.0K | $580.0K |
| Total Liabilities | $8.150M | $8.150M | $8.410M |
| YoY Change | -3.09% | -3.09% | |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$55.60M | ||
| YoY Change | |||
| Common Stock | $2.000K | ||
| YoY Change | |||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $25.54M | $25.54M | $16.92M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $33.69M | $33.69M | $25.33M |
| YoY Change | 33.0% | 33.0% |
Cashflow Statement
| Concept | 2021 Q4 | 2021 | 2020 Q4 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$7.393M | -$20.29M | -$6.250M |
| YoY Change | 18.29% | 68.23% | 137.64% |
| Depreciation, Depletion And Amortization | $168.2K | $733.0K | $180.0K |
| YoY Change | -6.54% | 1.81% | 0.0% |
| Cash From Operating Activities | -$4.122M | -$15.74M | -$3.620M |
| YoY Change | 13.87% | 177.02% | 130.57% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$382.6K | -$2.396M | -$90.00K |
| YoY Change | 325.17% | 1896.67% | 0.0% |
| Acquisitions | $225.0K | ||
| YoY Change | |||
| Other Investing Activities | $300.00 | -$212.0K | $0.00 |
| YoY Change | -100.0% | ||
| Cash From Investing Activities | -$382.4K | -$2.608M | -$90.00K |
| YoY Change | 324.83% | 2073.33% | -150.0% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | $25.00K | ||
| YoY Change | |||
| Cash From Financing Activities | -430.0 | 24.17M | 20.37M |
| YoY Change | -100.0% | 2.66% | 2616.0% |
| NET CHANGE | |||
| Cash From Operating Activities | -4.122M | -15.74M | -3.620M |
| Cash From Investing Activities | -382.4K | -2.608M | -90.00K |
| Cash From Financing Activities | -430.0 | 24.17M | 20.37M |
| Net Change In Cash | -4.505M | 5.824M | 16.66M |
| YoY Change | -127.04% | -67.17% | -2703.12% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$4.122M | -$15.74M | -$3.620M |
| Capital Expenditures | -$382.6K | -$2.396M | -$90.00K |
| Free Cash Flow | -$3.739M | -$13.34M | -$3.530M |
| YoY Change | 5.93% | 139.91% | 138.51% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2021Q4 | us-gaap |
Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
|
USD | |
| CY2021 | dei |
Auditor Firm
AuditorFirmId
|
166 | |
| CY2021 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
| CY2021 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
| CY2020Q4 | us-gaap |
Tenant Improvements
TenantImprovements
|
USD | |
| CY2021Q4 | us-gaap |
Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
|
USD | |
| CY2021Q4 | us-gaap |
Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
|
USD | |
| CY2020Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
USD | |
| CY2021Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
USD | |
| CY2020Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
USD | |
| CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2021Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
USD | |
| CY2021 | us-gaap |
Litigation Settlement Expense
LitigationSettlementExpense
|
USD | |
| CY2020 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
USD | |
| CY2020 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
USD | |
| CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
USD | |
| CY2021 | us-gaap |
Warrant Down Round Feature Increase Decrease In Equity Amount
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount
|
USD | |
| CY2020 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
USD | |
| CY2020 | us-gaap |
Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
|
USD | |
| CY2021 | VVOS |
Common Stock For Settlements
CommonStockForSettlements
|
USD | |
| CY2021 | VVOS |
Warrants Issued For Settlements
WarrantsIssuedForSettlements
|
USD | |
| CY2020 | us-gaap |
Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
|
USD | |
| CY2020 | us-gaap |
Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
|
USD | |
| CY2021 | us-gaap |
Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
|
USD | |
| CY2021 | us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
USD | |
| CY2021 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
USD | |
| CY2020 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
USD | |
| CY2020 | VVOS |
Fair Value Of Warrants Issued In Asset Purchase
FairValueOfWarrantsIssuedInAssetPurchase
|
USD | |
| CY2020 | VVOS |
Fair Value Of Warrants Issued In Business Acquisition
FairValueOfWarrantsIssuedInBusinessAcquisition
|
USD | |
| CY2020 | VVOS |
Fair Value Of Warrants Issued To Underwriters In Connection With Followon Offering
FairValueOfWarrantsIssuedToUnderwritersInConnectionWithFollowonOffering
|
USD | |
| CY2021 | us-gaap |
Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
|
USD | |
| CY2021 | us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
USD | |
| CY2021 | us-gaap |
Stock Issued1
StockIssued1
|
USD | |
| CY2021 | VVOS |
Exchange Of Series B Preferred Stock Into Common Shares
ExchangeOfSeriesBPreferredStockIntoCommonShares
|
USD | |
| CY2021 | VVOS |
Common Stock Issued For Payment Of Interest
CommonStockIssuedForPaymentOfInterest
|
USD | |
| CY2021Q4 | VVOS |
Empowered Dental Loan
EmpoweredDentalLoan
|
USD | |
| CY2021 | VVOS |
Series Preferred Stock Redemption Included In Accounts Payable
SeriesPreferredStockRedemptionIncludedInAccountsPayable
|
USD | |
| CY2021 | VVOS |
Series B Preferred Stock Issued For Payment Of Interest
SeriesBPreferredStockIssuedForPaymentOfInterest
|
USD | |
| CY2021Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
USD | |
| CY2020 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
shares | |
| CY2020 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
||
| CY2021 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
USD | |
| CY2020 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
USD | |
| CY2021 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
USD | |
| CY2020 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
USD | |
| CY2021 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
USD | |
| CY2020 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
USD | |
| CY2021 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
USD | |
| CY2020 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
USD | |
| CY2021 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
USD | |
| CY2020 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
USD | |
| CY2021 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
USD | |
| CY2020 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
USD | |
| CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
USD | |
| CY2020 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
USD | |
| CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
USD | |
| CY2020 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
USD | |
| CY2021Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
USD | |
| CY2020Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
USD | |
| CY2021Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
USD | |
| CY2020Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
USD | |
| CY2021Q4 | us-gaap |
Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
|
USD | |
| CY2021 | VVOS |
Warrant Beneficial Converison Feature
WarrantBeneficialConverisonFeature
|
USD | |
| CY2021 | VVOS |
Accretion Of Series Preferred Stock Redemption Amount
AccretionOfSeriesPreferredStockRedemptionAmount
|
USD | |
| CY2021Q4 | VVOS |
Payroll Protection Program Loan
PayrollProtectionProgramLoan
|
1265000 | USD |
| CY2020Q4 | VVOS |
Payroll Protection Program Loan
PayrollProtectionProgramLoan
|
1265000 | USD |
| CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.84 | |
| CY2020 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P1Y3M18D | |
| CY2021 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
5.23 | |
| CY2020 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
7.50 | |
| CY2021 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
6.25 | |
| CY2020 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
7.50 | |
| CY2021 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
200000 | shares |
| CY2021 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
1.65 | |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2851000 | shares |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.96 | |
| CY2021 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P3Y3M18D | |
| CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2302000 | shares |
| CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.84 | |
| CY2020 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P1Y3M18D | |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
1898000 | shares |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
4.53 | |
| CY2021 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P2Y8M12D | |
| CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
1673000 | shares |
| CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
4.10 | |
| CY2020 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P2Y6M | |
| CY2020 | VVOS |
Warrant Beneficial Converison Feature
WarrantBeneficialConverisonFeature
|
-3598000 | USD |
| CY2020 | VVOS |
Accretion Of Series Preferred Stock Redemption Amount
AccretionOfSeriesPreferredStockRedemptionAmount
|
-2333000 | USD |
